论文部分内容阅读
AIM:To investigate the influence,if any,of tumor necrosis factor(TNF)-αinihibitors and Tocilizumab,on hepatic steatosis(HS)in rheumatoid arthritis(RA)patients in the light of the known role of TNF-αand interleukin-6,which are key-cytokines in the pathogen